Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Depreciation and Depletion: 2011-2014

Historic Depreciation and Depletion for OptimizeRx (OPRX) over the last 4 years, with Q1 2014 value amounting to $1369.0.

  • OptimizeRx's Depreciation and Depletion fell 270.08% to $1369.0 in Q1 2014 from the same period last year, while for Mar 2014 it was $5590.0, marking a year-over-year increase of 66.63%. This contributed to the annual value of $111000.0 for FY2024, which is 1100.0% up from last year.
  • According to the latest figures from Q1 2014, OptimizeRx's Depreciation and Depletion is $1369.0, which was down 270.08% from $1407.0 recorded in Q4 2013.
  • OptimizeRx's Depreciation and Depletion's 5-year high stood at $1412.0 during Q2 2012, with a 5-year trough of $453.0 in Q3 2011.
  • Moreover, its 4-year median value for Depreciation and Depletion was $1382.0 (2012), whereas its average is $1254.3.
  • As far as peak fluctuations go, OptimizeRx's Depreciation and Depletion soared by 20507.73% in 2012, and later plummeted by 270.08% in 2014.
  • Quarter analysis of 4 years shows OptimizeRx's Depreciation and Depletion stood at $871.0 in 2011, then skyrocketed by 58.67% to $1382.0 in 2012, then grew by 1.81% to $1407.0 in 2013, then fell by 2.7% to $1369.0 in 2014.
  • Its Depreciation and Depletion was $1369.0 in Q1 2014, compared to $1407.0 in Q4 2013 and $1407.0 in Q3 2013.